Search

everythinglearnresearchcommunity

for

Search:↓

Certain factors like being female, having high cholesterol, using Medicaid, and previous non-biologic treatments increase the risk of multiple biologic failures in psoriasis patients.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

COPD flare-ups worsen life quality and increase hospital visits and costs.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Antiphospholipid syndrome can severely damage adrenal glands, requiring early diagnosis and treatment.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

Biologics and small molecules can effectively treat inflammatory nail disorders, but personalized treatment plans are important.

More research is needed to find the best treatment for dissecting cellulitis of the scalp.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Transforming skin disease treatment requires new strategies, better drug models, and patient-focused research.

Menopause is a clear hormonal transition in women, while men experience a gradual testosterone decline, with some needing lifestyle changes and targeted therapy.

Obesity worsens skin health and losing weight can improve skin conditions.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Sleep problems and skin issues affect each other; poor sleep can worsen skin conditions, and some skin treatments can improve or harm sleep quality.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.